Allspring Global Investments
INFI

Allspring Global Investments’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Allspring Global Investments’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-202,595
Closed -$230K – 3021
2022
Q1 		$230K Sell
202,595
-95,456
-32% -$114K ﹤0.01% 2529
2021
Q4 		$670K Buy
+298,051
New +$748K ﹤0.01% 2165

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Allspring Global Investments's INFI Position: Q2 2022 in Review

Allspring Global Investments sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 202,595 shares — an estimated $230K sold.

Allspring Global Investments first reported a position in INFI in Q4 2021 and held it in 2 quarters. The position peaked at $670K in Q4 2021. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • Allspring Global Investments reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 202,595 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $230K.
  • Allspring Global Investments first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Infinity Pharmaceuticals, Inc. position peaked at $670K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.